AIBioTech Receives Subcontract Award From DynPort Vaccine Company LLC, for Continued Development and FDA Approval of a Nerve Agent Prophylactic
5/23/2013 9:33:02 AM
More...
|
CSC's DynPort Vaccine Company LLC Wins $32.3 Million National Institute of Allergy And Infectious Diseases (NIAID) Contract to Establish Phase 1 Clinical Trial
7/14/2008 6:59:18 AM
More...
|
DynPort Vaccine Company LLC to Continue Plague Vaccine Development
6/5/2008 9:00:55 AM
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) to Provide Adjuvant to DynPort Vaccine Company LLC for Development of an Inactivated Vaccine against Venezuelan Equine Encephalitis Virus
4/30/2008 9:23:48 AM
More...
|
CSC's DVC And Baxter Begin Phase 1 Clinical Trial For Chemical Defense Product
1/18/2007 10:11:15 AM
More...
|
Computer Sciences Corporation (CSC) And DynPort Vaccine Company LLC Announces FDA Approval Of Vaccinia Immune Globulin To Treat Adverse Reactions To Smallpox Vaccination
10/19/2005 5:12:48 PM
More...
|
U.S. Approves Treatment For DynPort Vaccine Company LLC's Smallpox Shot Reaction
10/19/2005 5:12:47 PM
More...
|
DynPort Vaccine Company LLC Announces FDA Acceptance For Filing Of Vaccinia Immune Globulin BLA
10/19/2005 5:11:25 PM
More...
|
Avant Immunotherapeutics (AVAN) Receives Additional Defense Contract For Clinical Testing Of Plague Component For Oral Anthrax/Plague Vaccine
10/19/2005 5:10:59 PM
More...
|
Computer Sciences Corporation (CSC) - Porton Joint Venture DynPort Vaccine Company LLC Completes Preclinical Testing Of Plague Vaccine Candidate
10/19/2005 5:10:58 PM
More...
|
|